Table 3.
Differences in HRQOL by the occurrence of current comorbidities
| Comorbidities | SF-36 PCS | SF-36 MCS | ||||
|---|---|---|---|---|---|---|
| Reported? | F | Reported? | F | |||
| Yes | No | Yes | No | |||
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||
| Allergies | 52.2 (25.8) | 64.2 (23.0) | 5.67* | 58.9 (27.1) | 66.7 (22.0) | 2.14 |
| Arthritis | 45.2 (23.1) | 66.3 (22.1) | 15.03*** | 52.0 (25.1) | 68.7 (21.3) | 8.76** |
| High cholesterol | 58.9 (26.8) | 62.8 (23.2) | 0.33 | 59.6 (25.5) | 66.6 (22.3) | 1.37 |
| Diabetes | 58.3 (22.4) | 62.4 (23.9) | 0.19 | 59.0 (25.5) | 65.8 (22.8) | 0.64 |
| Eye/vision problems | 47.8 (21.4) | 67.6 (22.4) | 15.80*** | 54.2 (24.2) | 69.6 (21.1) | 8.49** |
| Dental problems | 46.7 (23.7) | 66.3 (22.1) | 16.37*** | 48.9 (25.1) | 69.8 (20.4) | 20.14*** |
| Hearing problems | 55.1 (22.1) | 63.0 (23.9) | 0.85 | 60.7 (23.6) | 66.0 (22.9) | 0.36 |
| Digestive problems | 49.5 (25.6) | 64.5 (22.8) | 4.43* | 56.2 (26.1) | 67.1 (22.1) | 2.01 |
| Chronic pain | 46.8 (27.8) | 65.6 (21.5) | 12.12** | 52.7 (27.5) | 68.2 (21.0) | 8.29** |
| Heart disease | 39.0 (18.6) | 63.9 (23.3) | 8.02** | 39.7 (19.5) | 67.3 (22.1) | 11.21** |
| High blood pressure | 65.0 (25.5) | 61.7 (23.6) | 0.87 | 64.9 (25.8) | 65.5 (22.6) | 0.06 |
| Osteoporosis | 54.1 (23.6) | 65.5 (23.1) | 4.69* | 61.3 (23.2) | 67.1 (22.8) | 0.63 |
| Lymphedema | 43.1 (24.0) | 66.2 (21.8) | 19.95*** | 45.3 (26.7) | 69.7 (19.7) | 25.6*** |
| Thyroid | 51.6 (16.3) | 63.7 (24.3) | 5.88* | 52.4 (19.9) | 67.3 (22.9) | 8.89** |
| Psychological difficulties | 47.4 (26.6) | 64.8 (22.3) | 5.45* | 41.8 (22.8) | 69.7 (20.3) | 25.43*** |
Note. A univariate general linear model was conducted, controlling for income, ethnicity, cancer stage, and hormonal therapy; PCS=Physical Component Summary; MCS=Mental Component Summary
*
p<0.05;
**
p<0.01;
***
p<0.001.